Zelnorm (also Zelmac) is the brand name for the pharmaceutical product Tegaserod, marketed by Novartis as a remedy for irritable bowel syndrome (IBS) and constipation. Zelnorm was introduced to the U.S. market in 2002, subsequent to Food and Drug Administration (FDA) approval.
In 2007, the FDA asked Novartis to take Zelnorm off the market, based on an analysis of data by the agency. After receiving reports that Zelnorm might be tied to increased risk of stroke or heart attack, the FDA reviewed data from more than 18,000 patients. The study showed that the incidences of cardiovascular problems of people who took Zelnorm was more than 10 times the rate of those who took a placebo.
If you or someone you love has suffered injury after being prescribed Zelnorm, GetLegal has the tools and resources to help you find skilled legal representation to protect your rights. Visit our attorney directory, look for your geographic location and find the best lawyer for your situation.
Defective Drugs & Medical Devices Topics
Four Types of Professional Malpractice
When you hear the word “malpractice,” what’s the first image that comes to mind? A doctor perf…Read More 14 Dec 2018, Friday
Sacred Sites and Ski Resorts: The Hopi Tribe and Reclaimed Wastewater
What constitutes a “public nuisance”? And does an injury rooted in religious belief override gen…Read More 13 Dec 2018, Thursday
Field Test Fail: When Traffic Stops Go Wrong
Traffic stops on New Year’s Eve may be a good way of deterring drunk driving, but a pair of Georgi…Read More 12 Dec 2018, Wednesday